StonvexLoading…
StonvexCore line items from GFF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $876.12M | $649.09M | $2.52B | $1.86B |
Operating Income | $186.76M | $113.36M | $206.28M | $87.26M |
Net Income | $83.70M | $64.39M | $51.11M | $7.47M |
EPS (Diluted) | $1.83 | $1.41 | $1.09 | $0.16 |
Total Assets | $2.07B | $2.05B | $2.08B | $2.09B |
Total Liabilities | $1.97B | $1.95B | $2.00B | $2.02B |
Cash & Equivalents | $109.67M | $95.28M | $99.05M | $107.28M |
Free Cash Flow OCF − CapEx | $100.66M | $99.33M | $305.00M | $242.61M |
Shares Outstanding | 46.12M | 46.57M | 46.35M | 46.91M |